Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 81,058 | 75,593 | 77,430 | 72,502 | 61,162 |
| Cost of Goods | 60,280 | 45,689 | 45,853 | 44,592 | N/A |
| Gross Profit | 30,550 | 29,904 | 31,577 | 27,910 | 61,162 |
| Operating Expenses | 17,070 | 12,745 | 14,217 | 13,270 | 0 |
| Operating Income | 3,988 | 17,848 | 18,213 | 15,232 | 61,162 |
| Interest Expense | 3,530 | 8,052 | 13,157 | 12,664 | 0 |
| Other Income | 10,586 | 687 | 516 | 753 | 0 |
| Pre-tax Income | 11,044 | 10,483 | 5,572 | 3,321 | 61,162 |
| Income Tax | 4,510 | 5,193 | -2,864 | 2,468 | N/A |
| Net Income Continuous | 4,428 | 4,839 | 7,974 | 636 | -2,828 |
| Net Income Extraordinary | N/A | -29,101 | N/A | N/A | N/A |
| Net Income | $4,428 | $-24,262 | $7,974 | $636 | $-2,828 |
| EPS Basic Total Ops | 0.12 | -0.69 | 0.40 | 0.03 | -0.14 |
| EPS Basic Continuous Ops | 0.12 | 0.14 | 0.40 | 0.03 | -0.14 |
| EPS Diluted Total Ops | 0.11 | -0.61 | 0.34 | 0.03 | -0.14 |
| EPS Diluted Continuous Ops | 0.11 | 0.12 | 0.34 | 0.03 | -0.14 |
| EBITDA(a) | $1,877 | $22,775 | $26,239 | $22,840 | $61,162 |